ACAD - ACADIA Pharmaceuticals Stock Trading

The following slide deck was published by ACADIA Pharmaceuticals Inc. in conjunction with their 2020 Q2 earnings Read more ...

ACADIA Pharmaceuticals, Inc. (ACAD) Q2 2020 Earnings Conference Call August 05, 2020, 16:30 ET Company Participants Mark Johnson - VP, IR Stephen Davis - CEO & Director Michael Yang - EVP & Chief Commercial Officer Srdjan Stankovic - President Elena Ridloff - EVP, CFO...

ACADIA Pharma (NASDAQ: ACAD ) : Q2 GAAP EPS of -$0.27 beats by $0.18 . Revenue of $110.1M (+32.3% Y/Y) beats by $6.69M . Shares +4% . Press Release More news on: ACADIA Pharmaceuticals Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news,